Document is current

Any future updates will be listed below

Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II Trial

Crossref DOI link: https://doi.org/10.1007/s10620-016-4276-1

Published Online: 2016-08-29

Published Print: 2016-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark